Angela K Green

4PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 25, 2026
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.

Maria M Rubinstein, Jennifer Y Ge, Qin Zhou

|Nov 19, 2024
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer.

Angela K Green, Qin Zhou, Alexia Iasonos

|Apr 21, 2021
Virtual Mind-Body Programming for Patients With Cancer During the COVID-19 Pandemic: Qualitative Study.

Nicholas Emard, Kathleen A Lynch, Kevin T Liou

|Aug 11, 2018
Racial disparities in chemotherapy administration for early-stage breast cancer: a systematic review and meta-analysis.

Angela K Green, Emeline M Aviki, Konstantina Matsoukas

Pageof 1

Frequent Collaborators

2 joint publications

Seth M Cohen

2 joint publications

Carol Aghajanian

2 joint publications

Maria M Rubinstein

2 joint publications

Rachel N Grisham